ARCA Biopharma

ABIO NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $176 $0 $0
Gross Profit -19 153 -30 -29
EBITDA -2,463 -1,567 -1,937 -1,973
EBIT -2,482 -1,590 -1,967 -2,002
Net Income -2,009 -1,089 -1,424 -958
Net Change In Cash 0 176 0 0
Free Cash Flow -1,528 -1,056 -1,669 -694
Cash 35,903 37,431 38,487 40,156
Basic Shares 14,501 14,501 14,410 14,410

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $0
Gross Profit -111 -114 -91 -93
EBITDA -7,296 -10,482 -19,322 -9,738
EBIT -7,296 -10,596 -19,335 -9,766
Net Income -5,339 -9,256 -19,231 -9,738
Net Change In Cash 0 0 0 0
Cost of Revenue 40,708
Free Cash Flow -5,014 -10,914 -18,805 -7,744
Cash 37,431 42,445 53,359 49,071
Basic Shares 14,415 14,410 13,903 4,710

Earnings Calls

Quarter EPS
2024-03-31 -$0.13
2023-12-31 -$0.07
2023-09-30 -$0.09
2023-06-30 -$0.10